Traumatic Intracranial Hemorrhage Clinical Trial
Official title:
Platelet Transfusion and Repeat Thromboelastography With Platelet Mapping (TEG-PM) in Patients With Severe Traumatic Brain Injuries (TBI) on Antiplatelet Therapy
The aim of this study is to see if administering platelets (cells in our blood that stop or prevent bleeding) results in improved platelet function and slows/stops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy (medications that stop blood cells from forming a blood clot) prior to admission.
This study aims to determine if platelet function has improved following platelet transfusion by prospectively performing repeat thromboelastographic with platelet mapping (TEG-PM) assays on all patients consented and enrolled in the study. This study will also examine the rate of progression or stability of ICH on repeat head CT following platelet administration and will aid in the determination of a potential association between repeat CT head findings and the repeat TEG-PM results. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05000060 -
Restart TICrH AP Pilot Trial
|
Phase 3 | |
Completed |
NCT05609721 -
Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
|
||
Completed |
NCT05609734 -
No Cases of Delayed Intracranial Hemorrhage (d-ICH) Among Patients With Mild Traumatic Brain Injury (mTBI) on Oral Anticoagulation Therapy
|
||
Completed |
NCT02728908 -
Detecting Traumatic Intracranial Hemorrhage With Microwave Technology
|
N/A |